2014•Shiyong yaowu yu linchuangRequires access

Comparative study between propafenone and sotalol in the treatment of persistent atrial fibrillation

Pan Dong-we

Open publisher page 0 citations

Abstract

Objective To compare the effect of propafenone and sotalol on persistent atrial fibrillation. Methods 50 patients with persistent atrial fibrillation were collected from January 2011 to March 2013 in our hospital,all the patients were randomly divided into sotalol group and propafenone group by random number table of the SAS analysis system. The cardioversion success rate,cardioversion,hospitalization time and recurrence rate,left atrial diameter, left ventricular ejection fraction,heart rate,QT interval and adverse reactions were compared between the two groups. Results The success rate of propafenone group was significantly higher than that of sotalol group(P 0. 05),the cardioversion and hospital stay were significantly shorter than those of sotalol group( P 0. 05),there was no significant difference in the recurrence rate between the two groups( P 0. 05). After treatment,no obvious difference was observed in left ventricular diameter and left ventricular ejection fraction( P 0. 05),but the heart rate decreased( P 0. 05),and QT interval was significantly longer( P 0. 05). There was no significant difference in left ventricular diameter,left ventricular ejection fraction,heart rate,QT interval between the two groups( P 0. 05). There were 8 cases and 7 cases of adverse reactions in sotalol group and propafenone group,there was no significant difference between the two groups( P 0. 05). Conclusion Short-term large dose of propafenone has better effect on cardioversion success rate and cardioversion time of persistent atrial fibrillation patients compared with sotalol,it is an effective treatment method for persistent atrial fibrillation.

About this research paper

What this paper is about

Objective To compare the effect of propafenone and sotalol on persistent atrial fibrillation. Methods 50 patients with persistent atrial fibrillation were collected from January 2011 to March 2013 in our hospital,all the patients were randomly divided into sotalol group and propafenone group by random number table of the SAS analysis system. The cardioversion success rate,cardioversion,hospitalization time and recurrence rate,left atrial diameter, left ventricular ejection fraction,heart rate,QT interval and adverse reactions were compared between the two groups. Results The success rate of propafenone group was significantly higher than that of sotalol group(P 0. 05),the cardioversion and hospital stay were significantly shorter than those of sotalol group( P 0. 05),there was no significant difference in the recurrence rate between the two groups( P 0. 05). After treatment,no obvious difference was observed in left ventricular diameter and left ventricular ejection fraction( P 0. 05),but the heart rate decreased( P 0. 05),and QT interval was significantly longer( P 0. 05). There was no significant difference in left ventricular diameter,left ventricular ejection fraction,heart rate,QT interval between the two groups( P 0. 05). There were 8 cases and 7 cases of adverse reactions in sotalol group and propafenone group,there was no significant difference between the two groups( P 0. 05). Conclusion Short-term large dose of propafenone has better effect on cardioversion success rate and cardioversion time of persistent atrial fibrillation patients compared with sotalol,it is an effective treatment method for persistent atrial fibrillation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the effect of propafenone and sotalol on persistent atrial fibrillation. Methods 50 patients with persistent atrial fibrillation were collected from January 2011 to March 2013 in our hospital,all the patients were randomly divided into sotalol group and propafenone group by random number table of the SAS analysis system. The cardioversion success rate,cardioversion,hospitalization time and recurrence rate,left atrial diameter, left ventricular ejection fraction,heart rate,QT interval and adverse reactions were compared between the two groups. Results The success rate of propafenone group was significantly higher than that of sotalol group(P 0. 05),the cardioversion and hospital stay were significantly shorter than those of sotalol group( P 0. 05),there was no significant difference in the recurrence rate between the two groups( P 0. 05). After treatment,no obvious difference was observed in left ventricular diameter and left ventricular ejection fraction( P 0. 05),but the heart rate decreased( P 0. 05),and QT interval was significantly longer( P 0. 05). There was no significant difference in left ventricular diameter,left ventricular ejection fraction,heart rate,QT interval between the two groups( P 0. 05). There were 8 cases and 7 cases of adverse reactions in sotalol group and propafenone group,there was no significant difference between the two groups( P 0. 05). Conclusion Short-term large dose of propafenone has better effect on cardioversion success rate and cardioversion time of persistent atrial fibrillation patients compared with sotalol,it is an effective treatment method for persistent atrial fibrillation.

Key concepts: Propafenone, Sotalol, Medicine, Cardioversion, Cardiology, Atrial fibrillation, Internal medicine, Ejection fraction

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study between propafenone and sotalol in the treatment of persistent atrial fibrillation — Research Paper | ScholarLens